Dapagliflozin + Pioglitazone
Information about Dapagliflozin + Pioglitazone
Dapagliflozin + Pioglitazone Uses
Dapagliflozin+Pioglitazone is used in the treatment of type 2 diabetes mellitus.
How Dapagliflozin + Pioglitazone works
Dapagliflozin + Pioglitazone is a combination of two medicines: dapagliflozin and pioglitazone. Dapagliflozin is an SGLT2 inhibitor (sodium-glucose cotransporter 2 inhibitor) and blocks the reabsorption of glucose in the kidneys. Pioglitazone improves the body’s responsiveness towards insulin and helps insulin resistance by cells. Together, they help address both insulin resistance and excess glucose, leading to effective and comprehensive blood sugar control.
Common side effects of Dapagliflozin + Pioglitazone
Limited data available
Available Medicine for Dapagliflozin + Pioglitazone
Gluxit-ProEris Lifesciences Ltd
₹2551 variant(s)
Siena PEris Lifesciences Limited
₹3001 variant(s)
Expert advice for Dapagliflozin + Pioglitazone
- Watch for symptoms of dehydration, such as dark urine, dry mouth, or lightheadedness, and if necessary, increase your water intake.
- Exercise aids in the control of diabetes; however, stay away from vigorous activities that may cause injury, particularly if your feet are swollen or sore.
- Inform your doctor about this medication before undergoing surgery or starting new treatments, as it may interact with other drugs or affect recovery.